Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 3
- 3
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Abstract 2466: Sequential tumor and immune targeted immunotherapy: Anti-tumor activity of antibody drug conjugate Trastuzumab Emtansine (T-DM1) with CD137 stimulation in HER-2+ breast cancer therapyCancer Research, 2015, 75 (15 Supplement), pp.2466--2466. ⟨10.1158/1538-7445.AM2015-2466⟩
Journal articles
hal-01300810v1
|
|||
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumorsCurrent Opinion in Immunology, 2015, Lymphocyte development and activation * Tumour immunology, 33, pp.1-8. ⟨10.1016/j.coi.2014.12.010⟩
Journal articles
hal-01104938v1
|
|||
|
Targeting CD137 enhances the efficacy of cetuximab.Journal of Clinical Investigation, 2014, 124 (6), pp.2668-82. ⟨10.1172/JCI73014⟩
Journal articles
hal-01021651v1
|